Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Beatriz Monje"'
Autor:
Beatriz Monje, Álvaro Giménez-Manzorro, Cristina Ortega-Navarro, Ana Herranz-Alonso, María Sanjurjo-Sáez
Publikováno v:
Revista Brasileira de Anestesiologia, Vol 69, Iss 3, Pp 259-265 (2019)
Abstract Background: Pain management committee established a pain performance improvement plan in 2012. Objectives: The aim of the study was to assess the trends in analgesic consumption in a tertiary teaching hospital and the associated economic imp
Externí odkaz:
https://doaj.org/article/da2d087b83de410cb388e1a80f214ef6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Emilio García-Cabrera, Maria Tovar Pozo, Federico Tutau Gómez, Irene Iglesias-Peinado, María Angeles Campos Fernández de Sevilla, Marta Gallego Úbeda, Beatriz Monje García, Laura Delgado Téllez de Cepeda
Publikováno v:
International Journal of Clinical Pharmacy. 41:1545-1554
Background Adherence to direct-acting antivirals could be a predictor response to these treatments in hepatitis C. Objective To assess the ability of three methods of measuring adherence to direct-acting antivirals [pill counts, pharmacy dispensing r
Autor:
C Ortega-Navarro, Ana Herranz-Alonso, Beatriz Monje, María Sanjurjo-Sáez, Alvaro Gimenez-Manzorro
Publikováno v:
Revista Brasileira de Anestesiologia, Vol 69, Iss 3, Pp 259-265 (2019)
Revista Brasileira de Anestesiologia v.69 n.3 2019
Revista Brasileira de Anestesiologia
Sociedade Brasileira de Anestesiologia (SBA)
instacron:SBA
Brazilian Journal of Anesthesiology, Vol 69, Iss 3, Pp 259-265 (2019)
Revista Brasileira de Anestesiologia v.69 n.3 2019
Revista Brasileira de Anestesiologia
Sociedade Brasileira de Anestesiologia (SBA)
instacron:SBA
Brazilian Journal of Anesthesiology, Vol 69, Iss 3, Pp 259-265 (2019)
Background: Pain management committee established a pain performance improvement plan in 2012. Objectives: The aim of the study was to assess the trends in analgesic consumption in a tertiary teaching hospital and the associated economic impact. Meth
Autor:
María Sanjurjo-Sáez, Beatriz Monje, Alvaro Gimenez-Manzorro, Ana Herranz-Alonso, C Ortega-Navarro
Publikováno v:
Brazilian Journal of Anesthesiology. 69:259-265
Resumo Justificativa A Comissao para o Manejo da Dor estabeleceu um plano de melhoria no controle da dor em 2012. Objetivo Avaliar as tendencias do consumo de analgesicos em um hospital de ensino terciario e o impacto economico associado. Metodos Est
Autor:
Xandra García-González, Almudena Ribed, Beatriz Monje, Mar Sánchez-Somolinos, Pablo Sanz-Ruiz, Carmen Guadalupe Rodríguez-González, María Sanjurjo-Sáez
Publikováno v:
Eur J Hosp Pharm
Objectives Infection following orthopaedic surgery is a feared complication and an indicator of the quality of the hospital. Surgical antibiotic prophylaxis (SAP) guidelines are not always properly followed. Our aim was to describe and evaluate the i
Autor:
Beatriz Monje, E García-Martín, Cristina Ruiz-Martínez, Sagrario Pernía-López, María Sanjurjo-Sáez, Pilar A Martínez-Ortega
Publikováno v:
Eur J Hosp Pharm
Hereditary haemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu disease, is a rare, vascular, autosomal dominant disorder. The purpose of this paper is to describe the efficacy and safety of treatment with intranasal bevacizumab in HHT.
Autor:
Emilio García-Cabrera, Maria Tovar Pozo, Miriam Heredia Benito, María Angeles Campos Fernández de Sevilla, Laura Delgado Téllez de Cepeda, Marta Gallego Úbeda, Irene Iglesias-Peinado, Beatriz Monje García
Publikováno v:
International journal of clinical pharmacy. 41(2)
Background A pharmaceutical care program is necessary to improve the management of direct-acting antivirals in hepatitis C. Objective Describe health outcomes obtained with the implementation of a pharmaceutical care program in Hepatitis C patients t
Autor:
María Sanjurjo-Sáez, Vicente Escudero-Vilaplana, Beatriz Monje, M Tovar-Pozo, JL Revuelta, C Ortega-Navarro, Xandra García-González
Publikováno v:
European Journal of Hospital Pharmacy. 23:A13.3-A14
Background In April 2009, lenalidomide was included in the hospital formulary for the treatment of multiple myeloma (MM) in patients who had received at least one previous therapy. The recommended starting dose (25 mg of lenalidomide) should be adjus
Autor:
C Ortega-Navarro, Vicente Escudero-Vilaplana, C Ruiz-Martínez, Beatriz Monje, JL Revuelta, María Sanjurjo-Sáez, Xandra García-González
Publikováno v:
European Journal of Hospital Pharmacy. 23:A127.2-A127
Background In 2009, lenalidomide was included in our hospital formulary for the treatment of multiple myeloma (MM). Presently, real world data are fundamental in the evaluation of drugs. Purpose To assess the effectiveness and safety of lenalidomide